Aviragen Therapeutics (AVIR) Misses Q4 EPS Views

September 14, 2016 4:04 PM EDT
Get Alerts AVIR Hot Sheet
Price: $1.30 +0.78%

Today's EPS Names:
PG, CFG, GE, More
Trade AVIR Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Aviragen Therapeutics (NASDAQ: AVIR) reported Q4 EPS of ($0.18), $0.43 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $60 thousand versus the consensus estimate of $21 million.

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment